Docgo Inc Stock Revenue Per Share

DCGO Stock  USD 2.91  0.12  3.96%   
DocGo Inc fundamentals help investors to digest information that contributes to DocGo's financial success or failures. It also enables traders to predict the movement of DocGo Stock. The fundamental analysis module provides a way to measure DocGo's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DocGo stock.
Last ReportedProjected for Next Year
Revenue Per Share 6.02  6.32 
As of the 10th of March 2025, Revenue Per Share is likely to grow to 6.32.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

DocGo Inc Company Revenue Per Share Analysis

DocGo's Revenue per Share is a ratio of total revenue earned per one share of common stock over a single fiscal year. It is calculated by dividing sales revenue earned over 12 months by the average number of outstanding shares. Revenue used in the calculation of this ratio is typically recorded when cash or cash equivalents are exchanged for services or goods.

Current DocGo Revenue Per Share

    
  6.32  
Most of DocGo's fundamental indicators, such as Revenue Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DocGo Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

DocGo Revenue Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for DocGo is extremely important. It helps to project a fair market value of DocGo Stock properly, considering its historical fundamentals such as Revenue Per Share. Since DocGo's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of DocGo's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of DocGo's interrelated accounts and indicators.
1.00.48-1.0-1.00.61-0.171.00.561.00.580.851.00.51.00.440.640.55-0.660.90.730.95
1.00.48-1.0-1.00.61-0.171.00.561.00.580.851.00.51.00.440.640.55-0.660.90.730.95
0.480.48-0.49-0.490.970.320.480.880.480.980.650.480.980.480.80.720.96-0.820.730.420.54
-1.0-1.0-0.491.0-0.630.17-1.0-0.57-1.0-0.59-0.85-1.0-0.5-1.0-0.44-0.64-0.550.66-0.91-0.7-0.97
-1.0-1.0-0.491.0-0.630.17-1.0-0.57-1.0-0.59-0.85-1.0-0.5-1.0-0.44-0.64-0.550.66-0.91-0.7-0.97
0.610.610.97-0.63-0.630.190.610.920.610.980.740.610.950.610.830.720.94-0.890.840.520.66
-0.17-0.170.320.170.170.19-0.17-0.16-0.170.16-0.21-0.170.44-0.17-0.170.630.470.2-0.19-0.16-0.16
1.01.00.48-1.0-1.00.61-0.170.561.00.580.851.00.51.00.440.640.55-0.660.90.730.95
0.560.560.88-0.57-0.570.92-0.160.560.560.940.80.560.80.560.960.430.77-0.970.840.550.61
1.01.00.48-1.0-1.00.61-0.171.00.560.580.851.00.51.00.440.640.55-0.660.90.730.95
0.580.580.98-0.59-0.590.980.160.580.940.580.780.580.950.580.890.680.93-0.910.820.550.62
0.850.850.65-0.85-0.850.74-0.210.850.80.850.780.850.640.850.80.560.66-0.830.880.780.8
1.01.00.48-1.0-1.00.61-0.171.00.561.00.580.850.51.00.440.640.55-0.660.90.730.95
0.50.50.98-0.5-0.50.950.440.50.80.50.950.640.50.50.740.810.99-0.780.680.50.51
1.01.00.48-1.0-1.00.61-0.171.00.561.00.580.851.00.50.440.640.55-0.660.90.730.95
0.440.440.8-0.44-0.440.83-0.170.440.960.440.890.80.440.740.440.340.7-0.920.710.570.45
0.640.640.72-0.64-0.640.720.630.640.430.640.680.560.640.810.640.340.87-0.460.590.470.61
0.550.550.96-0.55-0.550.940.470.550.770.550.930.660.550.990.550.70.87-0.760.70.510.56
-0.66-0.66-0.820.660.66-0.890.2-0.66-0.97-0.66-0.91-0.83-0.66-0.78-0.66-0.92-0.46-0.76-0.85-0.73-0.63
0.90.90.73-0.91-0.910.84-0.190.90.840.90.820.880.90.680.90.710.590.7-0.850.610.94
0.730.730.42-0.7-0.70.52-0.160.730.550.730.550.780.730.50.730.570.470.51-0.730.610.51
0.950.950.54-0.97-0.970.66-0.160.950.610.950.620.80.950.510.950.450.610.56-0.630.940.51
Click cells to compare fundamentals

DocGo Revenue Per Share Historical Pattern

Today, most investors in DocGo Stock are looking for potential investment opportunities by analyzing not only static indicators but also various DocGo's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue per share growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of DocGo revenue per share as a starting point in their analysis.
   DocGo Revenue Per Share   
       Timeline  
Revenue per share does not take into account any of company expenses and is helpful only when comparing relative sale figures within a given industry.
Competition

DocGo Common Stock Shares Outstanding

Common Stock Shares Outstanding

104.77 Million

At this time, DocGo's Common Stock Shares Outstanding is very stable compared to the past year.

DocGo Revenue Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DocGo's direct or indirect competition against its Revenue Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DocGo could also be used in its relative valuation, which is a method of valuing DocGo by comparing valuation metrics of similar companies.
6.0223.26195.76107.98100%
DocGo is currently under evaluation in revenue per share category among its peers.

DocGo Current Valuation Drivers

We derive many important indicators used in calculating different scores of DocGo from analyzing DocGo's financial statements. These drivers represent accounts that assess DocGo's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of DocGo's important valuation drivers and their relationship over time.
202020212022202320242025 (projected)
Market Cap592.5M750.7M715.7M578.6M434.2M752.4M
Enterprise Value573.9M591.7M578.3M565.8M(32.1T)(30.5T)

DocGo ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, DocGo's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to DocGo's managers, analysts, and investors.
53.0%
Environmental
57.3%
Governance
59.9%
Social

DocGo Fundamentals

Return On Equity0.0431
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-140%-120%-100%-80%-60%-40%-20%
Return On Asset0.0379
Profit Margin0.03 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-120%-100%-80%-60%-40%-20%
Operating Margin(0.06) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-12,000,000%-10,000,000%-8,000,000%-6,000,000%-4,000,000%-2,000,000%
Current Valuation276.95 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-3,000,000%-2,500,000%-2,000,000%-1,500,000%-1,000,000%-500,000%
Shares Outstanding101.98 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-40%-30%-20%-10%0%10%
Shares Owned By Insiders8.48 %
Shares Owned By Institutions53.76 %
Number Of Shares Shorted6.56 M
Price To Earning17.46 X
Price To Book0.96 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Price To Sales0.50 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Revenue616.56 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%1,200%
Gross Profit213.57 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%
EBITDA41.7 T
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-250,000,000%-200,000,000%-150,000,000%-100,000,000%-50,000,000%
Net Income13.36 T
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-250%-200%-150%-100%-50%
Cash And Equivalents198.14 M
Cash Per Share1.96 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150,000,000%100,000,000%150,000,000%200,000,000%
Total Debt57.19 T
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%100,000,000%200,000,000%300,000,000%
Debt To Equity0.06 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-60%-40%-20%0%
Current Ratio4.76 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-60%-50%-40%-30%-20%-10%
Book Value Per Share3.15 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100,000,000%200,000,000%300,000,000%400,000,000%
Cash Flow From Operations70.34 T
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-500,000,000%-400,000,000%-300,000,000%-200,000,000%-100,000,000%0%
Short Ratio10.60 X
Earnings Per Share0.18 X
Price To Earnings To Growth1.05 X
Target Price5.05
Number Of Employees3.4 K
Beta1.08
Market Capitalization309.01 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-50%-40%-30%-20%-10%
Total Asset455.62 T
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%100,000,000%200,000,000%300,000,000%400,000,000%
Retained Earnings(1.4 T)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500,000%1,000,000%1,500,000%2,000,000%
Working Capital182.68 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Net Asset455.62 T

About DocGo Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze DocGo Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DocGo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DocGo Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with DocGo

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DocGo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DocGo will appreciate offsetting losses from the drop in the long position's value.

Moving against DocGo Stock

  0.4BAX Baxter International Sell-off TrendPairCorr
  0.34LUNG Pulmonx CorpPairCorr
The ability to find closely correlated positions to DocGo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DocGo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DocGo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DocGo Inc to buy it.
The correlation of DocGo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DocGo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DocGo Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DocGo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DocGo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DocGo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Docgo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Docgo Inc Stock:
Check out DocGo Piotroski F Score and DocGo Altman Z Score analysis.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DocGo. If investors know DocGo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DocGo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.09
Earnings Share
0.18
Revenue Per Share
6.021
Quarterly Revenue Growth
(0.39)
Return On Assets
0.0379
The market value of DocGo Inc is measured differently than its book value, which is the value of DocGo that is recorded on the company's balance sheet. Investors also form their own opinion of DocGo's value that differs from its market value or its book value, called intrinsic value, which is DocGo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DocGo's market value can be influenced by many factors that don't directly affect DocGo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DocGo's value and its price as these two are different measures arrived at by different means. Investors typically determine if DocGo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DocGo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.